HIV Co-receptor usage in HIV-related non-hodgkin's lymphoma

被引：1

作者：

Reid, Erin ^{[1
]}

Morris, Sheldon R. ^{[2
]}

机构：

[1] Univ Calif San Diego, Dept Med, Div Hematol & Oncol, La Jolla, CA 92093 USA

[2] Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA 92103 USA

来源：

INFECTIOUS AGENTS AND CANCER | 2012年 / 7卷

关键词：

HIV; Non-hodgkins lymphoma; Co-receptor usage; CCR5; CXCR4; SDF-1; B-CELLS; CHEMOKINE; TROPISM; AIDS; EPIDEMIOLOGY; POPULATION; PREVALENCE; INFECTION; VIRUSES; RISK;

D O I：

10.1186/1750-9378-7-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In this study 15 banked samples of HIV-related Non-Hodgkin's Lymphoma (NHL) cases were tested for HIV coreceptor usage and SDF1 3'A polymorphism. Reportable tropism from 9 plasma samples had 1 (11.1%) HIV case with CXCR4 and 8 (88.9%) with CCR5 usage, even though most of the cases occurred at a late stage of HIV (2/3 had CD4 counts below 200), where expected CXCR4 usage would be 60%. Based on the expected proportion of less than 50% CCR5 in chronically infected individuals, this would suggest that in NHL may be associated with CCR5 usage (P = 0.04).

引用

页数：3

共 50 条

[21] Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study
Schommers, Philipp
Gillor, Daniel
Hentrich, Marcus
Wyen, Christoph
Wolf, Timo
Oette, Mark
Zoufaly, Alexander
Wasmuth, Jan-Christian
Bogner, Johannes R.
Mueller, Markus
Esser, Stefan
Schleicher, Alisa
Jensen, Bjoern
Stoehr, Albrecht
Behrens, Georg
Schultze, Alexander
Siehl, Jan
Thoden, Jan
Taylor, Ninon
Hoffmann, Christian
HAEMATOLOGICA, 2018, 103 (05) : 857 - 864
[22] HIV associated non-Hodgkin's lymphoma of the ovary
Bangera Yogesh K.
Shetty Darshit P.
Sethu S.
Pai P.
The Journal of Obstetrics and Gynecology of India, 2011, 61 (5) : 567 - 568
[23] Non-Hodgkin lymphoma in people with HIV
Aboulafia, David M.
LANCET HIV, 2019, 6 (04): : E209 - E210
[24] Assessing chemokine co-receptor usage in HIV
Coakley, E
Petropoulos, CJ
Whitcomb, JM
CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (01) : 9 - 15
[25] CLINICAL MANIFESTATIONS AND TREATMENT OF HIV RELATED NON-HODGKIN LYMPHOMA
NORTHFELT, DW
KAPLAN, LD
CANCER SURVEYS, 1991, 10 : 121 - 133
[26] The ''International Prognostic Index'' (IPI) is the most useful prognostic indicator in HIV-related non-Hodgkin's lymphoma.
Rossi, G
Donisi, A
Casari, S
Cadeo, GP
Carosi, G
BLOOD, 1997, 90 (10) : 3949 - 3949
[27] Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma
Thorball, Christian W.
Oudot-Mellakh, Tiphaine
Ehsan, Nava
Hammer, Christian
Santoni, Federico A.
Niay, Jonathan
Costagliola, Dominique
Goujard, Cecile
Meyer, Laurence
Wang, Sophia S.
Hussain, Shehnaz K.
Theodorou, Ioannis
Cavassini, Matthias
Rauch, Andri
Battegay, Manuel
Hoffmann, Matthias
Schmid, Patrick
Bernasconi, Enos
Gunthard, Huldrych F.
Mohammadi, Pejman
McLaren, Paul J.
Rabkin, Charles S.
Besson, Caroline
Fellay, Jacques
HAEMATOLOGICA, 2021, 106 (08) : 2233 - 2241
[28] HCV in HIV-related primary central nervous system non-Hodgkin's lymphomas.
Rosenthal, E
Sohn, C
Boissier, N
Pradier, C
Martin, IP
Gastaut, JA
Dujardin, P
Cassuto, JP
BLOOD, 1998, 92 (10) : 229B - 229B
[29] Immunotherapy for HIV-associated non-Hodgkin's lymphoma
Newsom-Davis, Thomas
Ahamed, Eliyaz
Bower, Mark
EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (10) : 1313 - 1324
[30] Treatment of HIV non-Hodgkin's lymphoma, a clinical overview
Kaplan, LD
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : S20 - S20

← 1 2 3 4 5 →